Anders Essen-Möller

Anders Essen-Möller

Net worth: 674 317 $ as of 29/09/2026

85 year
Health Technology
Finance
Technology Services

Profile

Anders Essen-Möller was the founder of Mertiva AB, founded in 1976, where the title held was Director from 2013 to 2014.
Mr. Essen-Möller was the founder of Synectics Medical AB, founded in 2015, where the title held was Chief Executive Officer & Director from 2015 to 2016.
Mr. Essen-Möller is the founder of Diamyd Medical AB, founded in 1996, where the title held is Chief Executive Officer & Director starting in 2026.
Current jobs include Director at Companion Medical, Inc., Director at Diamyd Diagnostics AB, and Director at Armea AB. Former jobs include Chairman at NextCell Pharma AB from 2018 to 2024 and Director at Novakand Pharma AB from 2010 to 2012.
Education includes a graduate degree from the University of Lund.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
30/03/2026 5,297,192 ( 3.5% ) 546 776 $ 29/09/2026
30/03/2026 1,235,620 ( 35.27% ) 127 541 $ 29/09/2026

Anders Essen-Möller active positions

CompaniesPositionStart
DIAMYD MEDICAL AB Founder 31/12/1995
Diamyd Diagnostics AB
Director/Board Member 09/05/2011
Armea AB
Director/Board Member 09/05/2011
Director/Board Member -

Former positions of Anders Essen-Möller

CompaniesPositionEnd
NEXTCELL PHARMA AB Chairman 19/05/2024
Founder 09/04/2016
MERTIVA AB Founder 20/02/2014
KANCERA AB Director/Board Member 27/03/2012
See the detail of Anders Essen-Möller's experience

Education of Anders Essen-Möller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

52

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Finance

Technology Services

Consumer Services

Health Technology

Health Technology

Diamyd Diagnostics AB

Armea AB

Health Technology

  1. Stock Market
  2. Insiders
  3. Anders Essen-Möller